These findings demonstrate a link between PPP2R5D pathogenic variants and neurodegeneration, highlighting the potential importance that therapeutic treatment for PPP2R5D-related NDD will have long-lasting effects and may curb early-onset parkinsonism. Here, PPP2R5D is linked to Parkinson disease.